Earnings calls

RUBICON concall ledger

Every earnings call for RUBICON — management tone, guidance, KPIs and promise tracking, quarter by quarter.

RUBICON · 2 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 03 Feb 2026Call held 03 Feb 2026

RUBICON Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹476 cr+52% YoYEBITDA₹112 cr+59% YoYPAT₹73 cr+91% YoYEPS₹4.41ROCE34%

Revenue ₹476 cr (+52% YoY); EBITDA ₹112 cr (+59% YoY); PAT ₹73 cr (+91% YoY). Revenue for Q3 FY26 was INR476 crores, marking a 52% year-on-year growth.

Read full transcript & analysis

Q2 FY26Published 13 Nov 2025Call held 13 Nov 2025

RUBICON Q2 FY26 Earnings Call Transcript & Analysis

EBITDA Margin22.9%Gross Margin68.7%

EBITDA Margin 22.9%; Gross Margin 68.7%. Revenue grew by 39% YoY, driven by new launches and growth in existing products.

Read full transcript & analysis